- Home
- RFM vs SRTS Comparison
RFM vs SRTS Comparison
Compare RFM & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RFM
- SRTS
- Stock Information
- Founded
- RFM 2020
- SRTS 2010
- Country
- RFM United States
- SRTS United States
- Employees
- RFM N/A
- SRTS N/A
- Industry
- RFM Finance/Investors Services
- SRTS Medical/Dental Instruments
- Sector
- RFM Finance
- SRTS Health Care
- Exchange
- RFM Nasdaq
- SRTS Nasdaq
- Market Cap
- RFM 86.0M
- SRTS 83.9M
- IPO Year
- RFM N/A
- SRTS 2016
- Fundamental
- Price
- RFM $13.89
- SRTS $4.71
- Analyst Decision
- RFM
- SRTS Strong Buy
- Analyst Count
- RFM 0
- SRTS 3
- Target Price
- RFM N/A
- SRTS $11.67
- AVG Volume (30 Days)
- RFM 20.7K
- SRTS 56.8K
- Earning Date
- RFM 01-01-0001
- SRTS 08-07-2025
- Dividend Yield
- RFM 9.74%
- SRTS N/A
- EPS Growth
- RFM N/A
- SRTS N/A
- EPS
- RFM N/A
- SRTS 0.11
- Revenue
- RFM N/A
- SRTS $39,488,000.00
- Revenue This Year
- RFM N/A
- SRTS $4.33
- Revenue Next Year
- RFM N/A
- SRTS $31.55
- P/E Ratio
- RFM N/A
- SRTS $42.74
- Revenue Growth
- RFM N/A
- SRTS 24.75
- 52 Week Low
- RFM $12.89
- SRTS $4.01
- 52 Week High
- RFM $16.41
- SRTS $9.33
- Technical
- Relative Strength Index (RSI)
- RFM 35.59
- SRTS 50.14
- Support Level
- RFM $13.91
- SRTS $4.72
- Resistance Level
- RFM $14.16
- SRTS $5.02
- Average True Range (ATR)
- RFM 0.09
- SRTS 0.21
- MACD
- RFM -0.02
- SRTS -0.03
- Stochastic Oscillator
- RFM 3.61
- SRTS 27.12
About RFM RiverNorth Flexible Municipal Income Fund Inc.
RiverNorth Flexible Municipal Income Fund Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.